Evox Therapeutics (NASDAQ:EVOXW) Stock Price Up 1.8% – Should You Buy?

Evox Therapeutics plc (NASDAQ:EVOXW)’s stock price was up 1.8% on Thursday . The stock traded as high as $0.3899 and last traded at $0.3970. Approximately 503 shares were traded during trading, a decline of 99% from the average session volume of 34,810 shares. The stock had previously closed at $0.3899.

Evox Therapeutics Stock Up 1.8%

The firm’s 50-day moving average is $0.39.

Evox Therapeutics plc is a biotechnology company developing therapeutics built on engineered extracellular vesicles (EVs), commonly referred to as exosomes, designed to deliver a broad range of therapeutic payloads. The company’s platform focuses on using naturally occurring nanoscale vesicles as vehicles to carry biologics—such as RNA, proteins and other macromolecules—into target cells and tissues. Evox aims to leverage the innate properties of EVs for targeted delivery, biodistribution and reduced immunogenicity compared with some synthetic delivery systems.

The company’s research and development activities center on engineering EVs for tissue-specific targeting and intracellular delivery, with the goal of addressing diseases that are difficult to treat with conventional approaches, including disorders of the central nervous system and certain rare genetic conditions.